- Home
- LNTH vs OKLO Comparison
LNTH vs OKLO Comparison
Compare LNTH & OKLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- OKLO
- Stock Information
- Founded
- LNTH 1956
- OKLO 2013
- Country
- LNTH United States
- OKLO United States
- Employees
- LNTH N/A
- OKLO N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OKLO
- Sector
- LNTH Health Care
- OKLO
- Exchange
- LNTH Nasdaq
- OKLO NYSE
- Market Cap
- LNTH 7.5B
- OKLO 7.0B
- IPO Year
- LNTH 2015
- OKLO N/A
- Fundamental
- Price
- LNTH $79.19
- OKLO $57.99
- Analyst Decision
- LNTH Strong Buy
- OKLO Strong Buy
- Analyst Count
- LNTH 5
- OKLO 9
- Target Price
- LNTH $133.80
- OKLO $58.14
- AVG Volume (30 Days)
- LNTH 1.0M
- OKLO 28.2M
- Earning Date
- LNTH 07-30-2025
- OKLO 08-12-2025
- Dividend Yield
- LNTH N/A
- OKLO N/A
- EPS Growth
- LNTH N/A
- OKLO N/A
- EPS
- LNTH 3.53
- OKLO N/A
- Revenue
- LNTH $1,536,699,000.00
- OKLO N/A
- Revenue This Year
- LNTH $4.63
- OKLO N/A
- Revenue Next Year
- LNTH $9.35
- OKLO N/A
- P/E Ratio
- LNTH $22.44
- OKLO N/A
- Revenue Growth
- LNTH 12.53
- OKLO N/A
- 52 Week Low
- LNTH $73.11
- OKLO $5.35
- 52 Week High
- LNTH $126.89
- OKLO $73.55
- Technical
- Relative Strength Index (RSI)
- LNTH 44.57
- OKLO 59.37
- Support Level
- LNTH $76.34
- OKLO $60.60
- Resistance Level
- LNTH $84.36
- OKLO $73.55
- Average True Range (ATR)
- LNTH 2.69
- OKLO 6.73
- MACD
- LNTH 0.66
- OKLO -0.20
- Stochastic Oscillator
- LNTH 48.07
- OKLO 45.40
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About OKLO OKLO INC
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.